In CRC, the lncRNA MIR155HG accelerates cancer progression and enhances oxaliplatin resistance by promoting M2 polarization as well as proliferation and metastasis of CRC cells by regulating the miR-650/ANXA2 axis (33). Here, ANXA2 is linked to colorectal carcinoma.